HOME >> MEDICINE >> NEWS
Problems at World Anti-Doping Agency will 'drive innocent athletes out of sport'

The current approach of the international agency responsible for fighting the use of drugs in sport will drive innocent athletes out of the Olympic Games, according to an article in the International Journal of Sports Science and Coaching.

The World Anti-Doping Agency (WADA) was set up in 1999 by the International Olympic Committee and publishes the list of banned substances and monitors drug use in sport through random tests.

In a review of some of the practices and procedures used by WADA, a leading sports scientist from the USA and a top marathon coach from the UK have identified major problems that they believe will lead to innocent athletes paying the price for a flawed anti-doping system.

Key to their finding was a lack of scientific evidence and protocol at the heart of WADA's operations.

"Drug testing and classification should be a scientific affair, unfortunately WADA appears to have little to no understanding of the criteria for science," said Dr Brent Rushall from San Diego State University, a four-time Olympic Team psychologist for Canada, who co-wrote the article with Max Jones, a multiple age-group world-record holding runner who has studied the drugs in sport movement.

"The actions and scope of WADA are causes for grave concern for the anti-drugs in sport movement. It is inevitable that if WADA continues its practices, professional athletes will be driven out of the Olympic Games."

Problems identified by the authors include:

  • Substances included in WADA's banned list are based on speculation rather than scientific evidence
  • WADA's clandestine sample collection procedures appear to ignore basic scientific guidelines
  • The way WADA lists banned substances does not conform to usual scientific practice, leading to confusion for coaches and athletes

    The authors cite the hysteria surrounding Anabolic Androgenic Steroids (AAS) as an example of WADA's poor use of science.
    '"/>



  • Contact: Dr Brent Rushall
    brushall@cox.net
    1-619-469-1537
    University of Bath
    17-Feb-2006


    Page: 1 2 3

    Related medicine news :

    1. Worlds largest respiratory health study launches next phase
    2. World first medical treatment announced by researchers
    3. World-leading innovation in child-allergy detection
    4. World-renowned chemist honored with inaugural lectureship
    5. IOF World Congress on Osteoporosis to be held for first time in Asia
    6. World first in medical robotics
    7. Worldwide Parkinsons cases will double in next 25 years
    8. Worldmapper draws attention to the worlds health inequalities
    9. World-class Biomedical Research Center to be in West London
    10. Worlds largest clinical trial into rare bone cancer well underway conference hears
    11. World-wide warning of highly drug-resistant tuberculosis

    Post Your Comments:
    (Date:4/23/2014)... Cancer Center researchers say clinical trials for a ... (AML) are very promising. Patients treated with CPX-351, ... daunorubicin, are showing better responses than patients treated ... , "Acute myeloid leukemia is an aggressive blood ... especially in older patients," explained Jeffrey Lancet, M.D., ...
    (Date:4/23/2014)... The American Society for Radiation Oncology (ASTRO) has ... Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based ... therapy in the treatment of endometrial cancer. The ... 2014 issue of Practical Radiation Oncology ... The full-length guideline is available as an open-access ...
    (Date:4/23/2014)... that targets an important brain receptor has a dramatic ... relapse behavior, a University at Buffalo animal study has ... may be a novel lead compound for treating cocaine ... research was published as an online preview article in ... the compound, RO5263397, severely blunted a broad range of ...
    (Date:4/23/2014)... that can rapidly screen a large cell population ... that population has been seriously lacking," said Virginia ... Royal Society of Chemistry journal Chemical Science ... coworkers have developed a novel technique that detects ... Sci. , 2014, DOI: 10.1039/C4SC00578C, http://pubs.rsc.org/en/content/articlelanding/2014/sc/c4sc00578c#!divAbstract ). ...
    (Date:4/23/2014)... Ill. - In a country as wealthy as the United ... 12 seniors do not have access to adequate food due ... food insecure. , Recent research at the University of ... Survey (NHANES) revealed that the seniors who are dealing with ... , "In 2011, 8.35 percent of Americans over age 60 ...
    Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2
    (Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
    (Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
    (Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
    Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
    Cached News: